Mucormycosis and aspergillosis: The deadly duo in COVID-19-a case report

Bijaya Mohanty1, Zeya Ansari1, Anil Prasad2

  • 1Department of Medicine, Jamshedpur, Jharkhand, India.

Insights

This case report details a rare dual fungal infection (aspergillosis and mucormycosis) with a superadded bacterial infection in a COVID-19 patient. Aggressive treatment led to the patient's recovery and successful discharge.

Area of Science:

  • Infectious Diseases
  • Mycology
  • Critical Care Medicine

Background:

  • COVID-19 is linked to fungal infections like aspergillosis and mucormycosis, particularly in diabetic patients receiving steroids.
  • Co-infections with mucormycosis during COVID-19 outbreaks have been reported, but dual fungal and bacterial infections are uncommon.

Observation:

  • A patient with a severe COVID-19 infection developed a rare "fungal storm" involving both aspergillosis and mucormycosis.
  • The fungal infection was further complicated by a superadded bacterial infection with Klebsiella.

Findings:

  • The patient underwent aggressive treatment including antifungal agents, antibiotics, and surgical debridement.
  • Multimodal therapy resulted in the patient's improvement and eventual discharge after a prolonged hospital stay.

Implications:

  • This case highlights the potential for complex, polymicrobial infections in severe COVID-19 patients.
  • Prompt and aggressive management is crucial for improving outcomes in patients with severe COVID-19 and co-infections.

Related Concept Videos

Fungal Group Zygomycota01:29

Fungal Group Zygomycota

Zygomycota, previously classified as a distinct fungal group, are primarily terrestrial, saprophytic molds that play a crucial role as decomposers. Recent phylogenetic studies have revealed that these fungi are now divided into two major clades — Mucoromycota, which includes many symbiotic species, and Zoopagomycota, which primarily consists of parasitic and pathogenic fungi. These groups exhibit distinct ecological roles and reproductive strategies while sharing key structural and...
74
Fungal Phylum Ascomycota01:28

Fungal Phylum Ascomycota

Phylum Ascomycota, a major division within the subkingdom Dikarya, comprises a diverse range of fungal species, including both unicellular yeasts and filamentous molds such as Aspergillus and Penicillium. These fungi thrive in a variety of habitats, from aquatic ecosystems to terrestrial environments, playing crucial ecological and economic roles.Morphology and ReproductionThe defining characteristic of Ascomycetes, commonly referred to as sac fungi, is the ascus—a sac-like structure that...
102
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
297
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
409
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
424
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
225